Erioflorin stabilizes the tumor suppressor Pdcd4 by blocking its interaction with β-TrCP1, suppresses the activity of AP-1 and NF-κB, and decelerates cancer cell proliferation (158). Here, NFKB1 is linked to neoplasm.